InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+14.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by DAVIS A BRIAN, Chief Financial Officer. Director active across 1 company, notably Verrica Pharmaceuticals Inc.. In total, 2 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €82k. History available since 4 June 2021. The latest transaction was filed on 4 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
5,000 shares@ US$9.890.038% mcap50.0% of flowCommon StockSEC:0001209191-21-038480:0
Ideal exit: 1 Mar 2022 (T+270)
5,000 shares@ US$9.8950.0% of flowCommon StockSEC:0001209191-21-038480
Ideal exit: 1 Mar 2022 (T+270)
2 of 2 declarations
About DAVIS A BRIAN
Brian A. Davis is the Chief Financial Officer at Verrica Pharmaceuticals Inc. He is responsible for the financial management of the company, including budgeting and financial analysis. Davis plays a crucial role in financial strategy.
